VIMOVO

Šalis: Izraelis

kalba: anglų

Šaltinis: Ministry of Health

Veiklioji medžiaga:

ESOMEPRAZOLE AS MAGNESIUM TRIHYDRATE 20 MG; NAPROXEN 500 MG

Prieinama:

ASTRA ZENECA ISRAEL LTD

ATC kodas:

G02CC02

Vaisto forma:

TABLETS MODIFIED RELEASE

Vartojimo būdas:

PER OS

Pagaminta:

ASTRA ZENECA AB., SWEDEN

Farmakoterapinė grupė:

NAPROXEN

Terapinės indikacijos:

Vimovo is a combination product that contains naproxen and esomeprazole. It is indicated for the relief of signs and symptoms of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis and to decrease the risk of developing gastric ulcers in patients at risk of developing NSAID-associated gastric ulcers. Vimovo is not recommended for initial treatment of acute pain because the absorption of naproxen is delayed compared to absorption from other naproxen-containing products.

Leidimo data:

2011-12-01